XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Net Income Attributable to Company Per Share
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Net Income Attributable to Company Per Share

12. Net Income Attributable to Company Per Share

The following table sets forth the computation of weighted average basic and diluted shares outstanding (in millions, except per share data):

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Company

$

42

 

 

$

130

 

 

$

223

 

 

$

475

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Basic—weighted average common shares outstanding

 

370

 

 

 

392

 

 

 

375

 

 

 

394

 

Dilutive effect of employee stock options and other
unvested stock awards

 

1

 

 

 

3

 

 

 

2

 

 

 

3

 

Diluted—weighted average common shares outstanding

 

371

 

 

 

395

 

 

 

377

 

 

 

397

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Company per share:

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.11

 

 

$

0.33

 

 

$

0.59

 

 

$

1.21

 

Diluted

$

0.11

 

 

$

0.33

 

 

$

0.59

 

 

$

1.20

 

 

 

 

 

 

 

 

 

 

 

 

Cash dividends per share

$

0.075

 

 

$

0.075

 

 

$

0.435

 

 

$

0.20

 

Companies with unvested participating securities are required to utilize a two-class method for the computation of net income attributable to Company per share. The two-class method requires a portion of net income attributable to Company to be allocated to participating securities, which are unvested awards of share-based payments with non-forfeitable rights to receive dividends or dividend equivalents if declared. Net income attributable to the Company allocated to these participating securities was immaterial for each of the three and nine months ended September 30, 2025 and 2024, respectively.

The Company had stock options outstanding that were anti-dilutive totaling 19 million and 16 million shares for the three and nine months ended September 30, 2025, respectively, compared to 17 million and 16 million shares for the three and nine months ended September 30, 2024, respectively.